Deucravacitinib in the treatment of psoriasis

Purpose of the article Psoriasis is a chronic, immune-mediated, skin disease with a significantly negative impact on patients’ quality of life. Moderate-to-severe disease often requires systemic therapies and currently available ones still have numerous disadvantages or limitations. Tyrosine kinase...

Full description

Bibliographic Details
Main Authors: Tomás Estevinho, Ana Maria Lé, Tiago Torres
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2022.2154122